-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Medtronic, Lowers Price Target to $120

Benzinga·04/13/2026 17:30:50
Listen to the news
Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $125 to $120.